Form 4: Verastem Director Eric K. Rowinsky Receives Stock Options and Restricted Stock Units

Director Eric K. Rowinsky received stock options and restricted stock units from Verastem, Inc. on June 18, 2024.

Summary

• On June 18, 2024, Eric K. Rowinsky, a director of Verastem, Inc., was granted 8,333 restricted stock units (RSUs) and stock options to purchase 12,500 shares of common stock.
• The RSUs vest in twelve equal monthly installments starting in June 2024 and ending in April 2025, with the final installment vesting no later than May 31, 2025, contingent upon continued service as a director.
• The stock options, with an exercise price of $3.27, also vest in twelve equal monthly installments over the same period, subject to the same condition of continued service as a director.
• Following these transactions, Rowinsky beneficially owns 8,333 shares of common stock and options to purchase 12,500 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of stock options and RSUs is a standard practice and generally viewed favorably as it aligns the interests of the director with those of the shareholders. There are no immediate negative implications.

Positives

• The grant of RSUs and stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule incentivizes continued service and commitment to the company's success.

Future Outlook

The vesting of the RSUs and stock options is contingent upon the reporting person's continued service as a director of the issuer.

Industry Context

This is a standard practice for incentivizing and retaining key personnel, aligning their interests with the long-term success of the company. Equity grants are common in the biotech industry to attract and retain talent.

Comparison to Industry Standards

• Equity compensation is a common practice in the biotechnology industry to incentivize directors and align their interests with shareholders.
• Companies like Amgen, Gilead Sciences, and Biogen also use stock options and restricted stock units as part of their compensation packages for board members.
• The vesting schedules are typical, often tied to continued service to ensure long-term commitment.

Stakeholder Impact

• Shareholders: Aligns director's interests with shareholder value.
• Employees: May boost morale knowing leadership is incentivized.
• Company: Retains a key director.

Key Dates